Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3856251 Title: COMBINAISON D'UN ANTAGONISTE DE PD-1, D'UN INHIBITEUR D'ATR ET D'UN AGENT DE PLATINATION POUR LE TRAITEMENT DU CANCER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
197832371
WO application number:
EP2019076116
Type:
European patent granted for BE
Status:
Open
Publication number:
3856251
WO publication number:
WO2020064971
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
26/09/2019
Grant date:
09/10/2024
EP publication date:
04/08/2021
WO publication date:
02/04/2020
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
09/10/2024
EP B1 publication date:
09/10/2024
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
26/09/2039

Applicant

1

Name:
Merck Patent GmbH
Legal Form:
From:
09/10/2024
Address:
Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)
To:

2

Name:
Pfizer Inc.
Legal Form:
From:
09/10/2024
Address:
66 Hudson Boulevard East, New York, NY 10001‐2192, United States (US)
To:

Inventor

1

Name:
ALIMZHANOV, Marat
Legal Form:
Address:
Wellesley, MA 02481, United States (US)

2

Name:
SOULARD, Patricia
Legal Form:
Address:
Lexington, MA 02421, United States (US)

3

Name:
ZENKE, Frank
Legal Form:
Address:
64291 Darmstadt, Germany (DE)

4

Name:
DAHMEN, Heike
Legal Form:
Address:
64293 Darmstadt, Germany (DE)

5

Name:
ZIMMERMANN, Astrid
Legal Form:
Address:
64367 Muehltal, Germany (DE)

6

Name:
SCHROEDER, Andreas
Legal Form:
Address:
69124 Heidelberg, Germany (DE)

7

Name:
TADJALLI MEHR, Keyvan
Legal Form:
Address:
69118 Heidelberg, Germany (DE)

8

Name:
FALK, Martin
Legal Form:
Address:
63322 Roedermark, Germany (DE)

Priority

Priority patent number:
201862736699 P
Priority date:
26/09/2018
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 39/395; A61K 45/06; A61P 35/00; A61K 31/555; A61K 33/243; A61K 31/519; A61K 31/5377; A61K 31/497;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2024/19
Publication date:
09/12/2024
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202441
Publication date:
09/10/2024
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
30/09/2025
Annual fee number:
7
Annual fee amount:
110 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type